Fate Financial Statements From 2010 to 2025
| FATE Stock | USD 0.98 0.01 1.03% |
Check Fate Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fate Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Fate financial statements analysis is a perfect complement when working with Fate Therapeutics Valuation or Volatility modules.
Check out the analysis of Fate Therapeutics Correlation against competitors. Fate Therapeutics Company Operating Margin Analysis
Fate Therapeutics' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Fate Therapeutics Operating Margin | (19.39) % |
Most of Fate Therapeutics' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fate Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Fate Therapeutics has an Operating Margin of -19.3854%. This is 44.74% lower than that of the Biotechnology sector and 82.7% lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
Fate Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Fate Therapeutics's current stock value. Our valuation model uses many indicators to compare Fate Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fate Therapeutics competition to find correlations between indicators driving Fate Therapeutics's intrinsic value. More Info.Fate Therapeutics is rated # 4 in return on equity category among its peers. It also is rated # 4 in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Fate Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Fate Therapeutics Financial Statements
Fate Therapeutics stakeholders use historical fundamental indicators, such as Fate Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Fate Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Fate Therapeutics' assets and liabilities are reflected in the revenues and expenses on Fate Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Fate Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California. Fate Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 542 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Fate Therapeutics is a strong investment it is important to analyze Fate Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fate Therapeutics' future performance. For an informed investment choice regarding Fate Stock, refer to the following important reports:Check out the analysis of Fate Therapeutics Correlation against competitors. For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fate Therapeutics. If investors know Fate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Fate Therapeutics is measured differently than its book value, which is the value of Fate that is recorded on the company's balance sheet. Investors also form their own opinion of Fate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fate Therapeutics' market value can be influenced by many factors that don't directly affect Fate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.